Comparative Effectiveness of Angiotensin-Receptor Blockers for Preventing Macrovascular Disease in Patients With Diabetes: A Population-Based Cohort Study

CMAJ - Canada
doi 10.1503/cmaj.121771
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers for Major Renal Outcomes in Patients With Diabetes: A 15-Year Cohort Study

PLoS ONE
Multidisciplinary
2017English

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Liver Cirrhosis: A Nationwide Cohort Study

Gastroenterology Research and Practice
HepatologyGastroenterology
2019English

Organoprotecive Effects of Angiotensin II Receptor Blockers in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

A Study on Utilization of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Cardiovascular Diseases

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Cost-Effectiveness of Pioglitazone in Type 2 Diabetes Patients With a History of Macrovascular Disease: A German Perspective

Cost Effectiveness and Resource Allocation
Health Policy
2009English

Comparative Assessment of Angiotensin Receptor Blockers in Different Clinical Settings

Vascular Health and Risk Management
2009English

Increased Risk of Alzheimer’s Disease in Patients With Psoriasis: A Nationwide Population-Based Cohort Study

Scientific Reports
Multidisciplinary
2020English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy